OESOPHAGUS

Mortality in Barrett’s oesophagus: results from a population based study

L A Anderson¹, L J Murray¹, S J Murphy¹, D A Fitzpatrick¹, B T Johnston², R G P Watson³, P McCarron¹ and A T Gavin¹

¹ Northern Ireland Cancer Registry, Department of Epidemiology and Public Health, The Queen’s University Belfast, UK
² The Royal Hospitals Trust, Belfast, UK
³ Department of Medicine, The Queen’s University Belfast, UK

Correspondence to:
Correspondence to:
L A Anderson, Northern Ireland Cancer Registry, Department of Epidemiology and Public Health, The Queen’s University Belfast, Mulhouse Building, Belfast BT12 6BJ, UK;
l.anderson{at}qub.ac.uk

Background: Patients with Barrett’s oesophagus have an increased risk of oesophageal adenocarcinoma but this cancer only accounts for a small proportion of deaths in these patients. Other causes of death are reportedly raised in this group. We examined cause specific mortality among individuals in a population based Barrett’s oesophagus register.

Methods: We constructed a register of all patients diagnosed with columnar mucosa (including specialised intestinal metaplasia) of the oesophagus within Northern Ireland between 1993 and 1999. Deaths occurring within this cohort until 31 December 2000 were identified and mortality rates were compared with the general population.

Results: Overall mortality was not raised in Barrett’s patients. During 7413 person years of follow up in 2373 patients there were 253 deaths (standardised mortality ratio (SMR) 96 (95% confidence interval (CI) 84–107)). Mortality from oesophageal cancer was raised in patients with specialised intestinal metaplasia (SMR 774 (95% CI 317–1231)) but only 4.7% of patients died from this cancer. Mortality from stroke (SMR 65 (95% CI 37–93)) was significantly lower than the general population while mortality from non-cancerous digestive system diseases was significantly higher (SMR 211 (95% CI 111–311)). Mortality rates from all other causes were similar to those of the general population.

Conclusions: This study demonstrates that the overall mortality rate in patients with Barrett’s oesophagus is closely similar to that of the general population. Oesophageal cancer mortality was raised but is an uncommon cause of death in these patients who also appear to have a reduced risk of death from stroke.

Keywords: Barrett’s oesophagus; mortality; cancer; stroke

Abbreviations: BO, Barrett’s oesophagus; OAC, oesophageal adenocarcinoma; NI, Northern Ireland; OGJ, oesophagogastric junction; SIM, specialised intestinal metaplasia; SMR, standardised mortality ratio

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Barrett’s oesophagus: epidemiology comes up with a surprise

R C Heading
Gut 2003 52: 1079-1080. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Paulson, T. G., Maley, C. C., Li, X., Li, H., Sanchez, C. A., Chao, D. L., Odze, R. D., Vaughan, T. L., Blount, P. L., Reid, B. J. (2009). Chromosomal Instability and Copy Number Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma. Clin. Cancer Res. 15: 3305-3314 [Abstract] [Full Text]  
• Li, X., Galipeau, P. C., Sanchez, C. A., Blount, P. L., Maley, C. C., Arnaudo, J., Peiffer, D. A., Pokholok, D., Gunderson, K. L., Reid, B. J. (2008). Single Nucleotide Polymorphism-Based Genome-Wide Chromosome Copy Change, Loss of Heterozygosity, and Aneuploidy in Barrett's Esophagus Neoplastic Progression. Cancer Prevention Research 1: 413-423 [Abstract] [Full Text]  
• Smith, M. S., Lightdale, C. J. (2008). Review: Barrett's esophagus and the increasing role of endoluminal therapy. Therapeutic Advances in Gastroenterology 1: 121-142 [Abstract]  
• Reid, B. J. (2008). Cancer Risk Assessment and Cancer Prevention: Promises and Challenges. Cancer Prevention Research 1: 229-232 [Full Text]  
• Cook, M. B., Wild, C. P., Everett, S. M., Hardie, L. J., Bani-Hani, K. E., Martin, I. G., Forman, D. (2007). Risk of Mortality and Cancer Incidence in Barrett's Esophagus. Cancer Epidemiol. Biomarkers Prev. 16: 2090-2096 [Abstract] [Full Text]  
• Murray, L, Sedo, A, Scott, M, McManus, D, Sloan, J M, Hardie, L J, Forman, D, Wild, C P (2006). TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort. Gut 55: 1390-1397 [Abstract] [Full Text]  
• (2006). Dilemmas in managing Barrett's oesophagus. DTB 44: 69-72 [Abstract] [Full Text]  
• Sharma, P, Wani, S, Weston, A P, Bansal, A, Hall, M, Mathur, S, Prasad, A, Sampliner, R E (2006). A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results.. Gut 55: 1233-1239 [Abstract] [Full Text]  
• Fox, M., Forgacs, I. (2006). Gastro-oesophageal reflux disease. BMJ 332: 88-93 [Full Text]  
• Cook, M. B., Wild, C. P., Forman, D. (2005). A Systematic Review and Meta-Analysis of the Sex Ratio for Barrett's Esophagus, Erosive Reflux Disease, and Nonerosive Reflux Disease. Am J Epidemiol 162: 1050-1061 [Abstract] [Full Text]  
• Souza, R. F., Spechler, S. J. (2005). Concepts in the Prevention of Adenocarcinoma of the Distal Esophagus and Proximal Stomach. CA Cancer J Clin 55: 334-351 [Abstract] [Full Text]  
• Ford, A. C., Forman, D., Reynolds, P. D., Cooper, B. T., Moayyedi, P. (2005). Ethnicity, Gender, and Socioeconomic Status as Risk Factors for Esophagitis and Barrett's Esophagus. Am J Epidemiol 162: 454-460 [Abstract] [Full Text]  
• Dellon, E. S., Shaheen, N. J. (2005). Does Screening for Barrett's Esophagus and Adenocarcinoma of the Esophagus Prolong Survival?. JCO 23: 4478-4482 [Abstract] [Full Text]  
• Davydova, J., Le, L. P., Gavrikova, T., Wang, M., Krasnykh, V., Yamamoto, M. (2004). Infectivity-Enhanced Cyclooxygenase-2-Based Conditionally Replicative Adenoviruses for Esophageal Adenocarcinoma Treatment. Cancer Res. 64: 4319-4327 [Abstract] [Full Text]  
• (2003). Mortality in Barrett's Esophagus Patients. JWatch Gastroenterology 2003: 3-3 [Full Text]  
• Heading, R C (2003). Barrett's oesophagus: epidemiology comes up with a surprise. Gut 52: 1079-1080 [Full Text]